Brainstorm Cell Therapeutics INC.

Brainstorm Cell Therapeutics INC. is a publicly traded company headquartered in New York City[1]. The company is listed on the OTC market under the ticker symbol BCLI[2] and holds SEC CIK number 1137883[2]. According to SEC classification, the company operates in the biological products industry, excluding diagnostic substances[3]. The company's registered business address is located at 1325 Avenue of Americas, 28th Floor, New York, NY, 10019[1]. Brainstorm Cell Therapeutics INC. adopted its current name in 2004[4], having previously operated under the names Golden Hand Resources INC[5] and Wizbang Technologies INC[6]. As of its most recent annual SEC filing, the company reported total assets of $1.0 million[7].

Something wrong or missing? Send a correction. Fixed within 24 hours.